Multiplikator Forward P/S: TELA Bio Inc. (TELA)
Geopolitical risks and logistics disruptions are limiting TELA Bio, Inc. (TELA) access to raw materials and markets, as clearly demonstrated by the company's forward P/S chart, where the metric stands at 0.50. Fundamental stability is provided by innovative OviTex implants with a unique structure and expansion into the reconstructive surgery niche through biosynthetic solutions that minimize the risk of complications.
Ringkesan rincian data analitis telabio.com (TELA)
- rega pasar lan target rega analis:
- indikator kapitalisasi bursa perusahaan:
- statistik nilai buku emiten:
- data utang lan likuiditas:
Total Utang marang Modal TELA Bio, Inc.|TELA - Rasio utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal TELA Bio|TELA - Gunggung utang perusahaan|Rasio utang marang kapitalisasi buku TELA Bio, Inc.|TELA - Utang jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan TELA Bio|Rasio cepet telabio.com
- rincian asil keuangan lan kelipatan valuasi:
TELA - Penghasilan resik perusahaan|Bathi sing dikarepake TELA Bio, Inc.|TELA - Rasio kapitalisasi marang bathi resik|Prakiraan rega marang bathi TELA Bio|TELA - Pangali PEG|Pangali EV/EBITDA TELA Bio, Inc.|TELA - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi saben saham sajrone rolas wulan pungkasan TELA Bio|TELA - Bathi saben siji saham sajrone 12 wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan telabio.com|TELA - Wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi kanggo taun ngarep TELA Bio, Inc.
- indikator dodolan lan pendapatan:
Analisis fundamental perusahaan:TELA (TELA Bio Corp)
Investors utilize this tool to determine the market value of a business relative to its future cash flows. The forward price-to-sales ratio compares current market capitalization with expected revenue for the following year, identifying whether an asset is undervalued or carries hidden risks. For TELA Bio, Inc. (TELA), low forward price-to-sales values may overlook the high loyalty of surgeons to the unique OviTex hybrid meshes.
Karo sapa TELA Bio, Inc. saingan
Rasio rega marang prakiraan pendapatan Dexcom DXCM|PEN - Multiplikator forward rega marang pendapatan|Novanta Corp - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Haemonetics Company|INSP: Multiplikator Forward P/S|Kapitalisasi marang prakiraan pendapatan PRCT|CNMD (CONMED) - Multiplikator Forward P/S|Pulse Biosciences Inc (PLSE) - Rasio kapitalisasi marang dodolan sing dikarepake|Multiplikator Forward P/S INMD|Multiplikator forward rega marang pendapatan Picard Group PMI|Multiplikator Forward P/S SRDX (Surmodics, Inc.)|Multiplikator Forward P/S senseonics.com SENS|NPCE - Rasio rega marang prakiraan pendapatan|TCMD: Rasio rega marang prakiraan pendapatan|SNWV (SANUWAVE Health, Inc.) - Multiplikator forward rega marang pendapatan|Outset Medical Corp - Rega forward marang dodolan|ELMD (SmartVest) - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep lensar.com LNSR|Rasio rega marang prakiraan pendapatan AVITA Medical (RCEL)|profoundmedical.com (PROF) - Prakiraan rega marang pendapatan|Baird Medical - Multiplikator forward rega marang pendapatan|Multiplikator Forward P/S EDAP TMS SA EDAP|Bovie Medical - Multiplikator Forward P/S|Rasio kapitalisasi marang dodolan sing dikarepake IceCure Medical Ltd ICCM|pulmonx.com (LUNG) - Rasio rega marang prakiraan pendapatan|Rega mangsa ngarep marang pendapatan CTSO (CytoSorbents Corporation)|Rasio rega marang prakiraan pendapatan Sensus Healthcare Corp|Multiplikator forward rega marang pendapatan Zynex Corp (ZYXI)|Multiplikator Forward P/S ECOR|RBOT - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Rasio rega marang prakiraan pendapatan Inspira Technologies IINN|ICU: Kapitalisasi marang prakiraan pendapatan|IRIX: Multiplikator forward rega marang pendapatan|Intelligent Bio Solutions - Rasio rega marang pendapatan sing dikarepake|XAIR (beyondair.net) - Multiplikator forward rega marang pendapatan|PFSA: Rasio rega marang pendapatan sing dikarepake|SSKN (STRATA Skin Sciences Inc.) - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep glucotrack.com GCTK|Rasio rega marang prakiraan pendapatan NanoVibronix (NAOV)|Rasio rega marang prakiraan pendapatan VERO (Venus Concept Corporation)|Multiplikator Forward P/S NUWE (Nuwellis, Inc.)|Multiplikator Forward P/S aethlonmedical.com AEMD|ASXC: Multiplikator forward rega marang pendapatan|Rega forward marang dodolan AVGR (Avinger Inc.)|BSGM: Multiplikator Forward P/S|CUTR (Cutera Inc) - Rasio rega marang prakiraan pendapatan|KNW (Know Labs, Inc.) - Multiplikator Forward P/S|inarimedical.com (NARI) - Rasio kapitalisasi marang dodolan sing dikarepake|Rasio rega marang prakiraan pendapatan Nevro (NVRO)|RSLS - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Silk Road Medical Inc. - Multiplikator forward rega marang pendapatan
